ARS Pharmaceuticals (NASDAQ:SPRY) partners with ALK to co-promote neffy, an epinephrine nasal spray, to 9,000 pediatricians.

It’s election this weekend in Australia, and we’re all preparing to dictate what the next three years of our lives will look ...

Emergent BioSolutions signed an agreement worth around $65 million to supply the Ontario Ministry of Health with Narcan nasal spray. The contract will last a maximum of three years and supports the ...

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

Unlike older medications that target serotonin – a “feel-good” chemical in the brain – the ketamine-based nasal spray works ...